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Cerebrospinal fluid (CSF) and peripheral blood pleocytosis have been observed after epileptic seizures without any evidence
of infections, but no systematic studies on the acute phase reaction in such patients have been performed. We have previously
reported increased levels of interleukin-6 (IL-6) in patients with recent tonic–clonic seizures. Because IL-6 is a major inducer of
the systemic acute phase reaction, we decided to study various indicators of inflammation in the blood as well as their correlation
with plasma and CSF IL-6 levels. CSF and blood samples were studied from 37 patients with previously undiagnosed and
untreated tonic–clonic seizures without any clinical evidence of systemic or central nervous system infections as well as from
40 controls. The mean peripheral blood and CSF-leukocyte counts were significantly higher in patients compared with controls
(7.9 × 109 vs. 6.1 × 109, P = 0.002 and 1.9 × 106 vs. 1.1 × 106, P = 0.032, respectively). There was some indication of
increased concentration of C-reactive protein (CRP) and no difference in haptoglobin levels. There was a significant correlation
between plasma but not CSF IL-6 concentration and those of both B-leukocyte count (r = 0.051, P = 0.009) and CRP
(r = 0.42, P = 0.009). Epileptic seizures provoke a production of cytokines such as IL-6 that may in turn cause an activation
of the acute phase reaction. Thus, CSF pleocytosis and increase in some indicators of inflammation should not automatically be
attributed to systemic or CNS infections in patients with acute seizures.
c© 2001 BEA Trading Ltd
Key words: seizures; cytokines; acute phase reaction; interleukin-6; cerebrospinal fluid.
INTRODUCTION
Both experimental and clinical data suggest that
activation of inflammation may occur after epileptic
seizures without any evidence of systemic or central
nervous system (CNS) infection. Cerebrospinal fluid
(CSF) pleocytosis was observed in some patients
with single seizures or status epilepticus1–4 and
electrically provoked convulsions induced peripheral
blood leukocytosis in rabbits5. We have previously
reported increased levels of interleukin-6 (IL-6) in
CSF of patients with newly diagnosed tonic–clonic
seizures without any evidence of infection or CNS
trauma6, 7. IL-6 and other proinflammatory cytokines
such as tumor necrosis factor-α (TNF-α) and IL-1 play
an important role in the induction of a systemic acute
phase reaction8. To our knowledge, no systematic
studies on the acute phase reaction in patients
with epileptic seizures have been performed. As
CSF pleocytosis may be seizure related and not
an indication of CNS infection, it is important in
the clinical management of the patients with acute
seizures to address the question of acute phase reaction
without any evidence of systemic or CNS infection. In
the present study we investigated various indicators of
inflammation in the blood as well as their correlation
with plasma and CSF IL-6 levels.
PATIENTS AND METHODS
The patient group consists of 37 patients with
previously undiagnosed and untreated tonic–clonic or
partial secondarily generalized seizures. The patient
group represent the pooled population from our two
previous studies addressing IL-6 concentrations6, 7,
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whereas the acute phase reactants have not been
reported previously. Patients were studied within
72 hours after the seizure. 17 patients had recurrent
and 20 patients had a single seizure. Six seizures
were due to alcohol withdrawal. Patients with seizures
due to electrolyte disturbances, metabolic causes,
acute brain disease or trauma were excluded. There
was no clinical evidence of recent systemic or
CNS infection in any patients. The mean age was
35.6 years (range 16–60 years). After the first
epileptic seizure, patients were examined by EEG and
computed tomography (CT) or magnetic resonance
imaging (MRI). Cerebral tumor was diagnosed in
five patients, while the remaining patients had normal
CT/MRI findings. All patients were informed of
the risks and benefits of the CSF examination, and
informed consent was obtained from each subject. The
study protocol was approved by the Ethics Committee
of Tampere University Hospital.
The control samples were obtained from 40 adult
patients (mean age 40.3, range 16–67 years) on whom
CSF examination was performed to exclude neurolog-
ical disease and who yielded normal neurological and
laboratory findings.
Lumbar CSF was obtained between 9 a.m. and
2 p.m. The first 2 ml was used for routine examination
and a further 0.2 ml for the present study. Blood
was collected within 30 minutes after lumbar puncture
in Vacutainer EDTA vacuum tube and centrifuged
at 3000 rpm for 10 minutes. The plasma and
CSF samples were stored at −70 ◦C until analysis.
Haemolysed samples were not included for the
analysis.
The completed blood count (CBC) was determined
using Coulter Counter Model S-Plus IV (Coulter
Group, Hialeah, FL) and C-reactive protein (CRP)
by immunoturbidimetry (Hitachi Ltd, Tokyo, Japan).
Fibrinogen and haptoglobin concentrations were
analysed by immunoturbidimetry (Aca, Dupoint)
and nephelometric method (Dade Behring, Marburg,
Germany), respectively.
Statistical methods: The mean and standard devia-
tions were calculated for continuous variables. Statis-
tical significance of differences between groups was
tested by independent two-tailed t-test for continuous
variables. Associations between continuous variables
were assessed with Pearson’s correlation coefficient.
All analyses were performed using a microcomputer
and Statistica/Win package (version 5.1; Statsoft, Inc,
Tulsa, USA) A P value less than 0.05 was considered
statistically significant.
RESULTS
The B-leukocyte and CSF leukocyte counts were
higher in patients than in controls (Table 1). CSF
pleocytosis (defined as >3×106 while blood cells l−1)
Table 1: The mean concentrations of inflammatory proteins,
leukocyte counts and both CSF IL-6 and plasma IL-6 from
patients with recent tonic–clonic seizures and controls.
Patients Controls P
(Mean; SD) (Mean; SD)
Blood-leukocytes 7.9 (2.8) 6.1 (1.8) 0.002
(109 l−1)
CSF-leukocytes 1.9 (2.0) 1.1 (1.3) 0.046
(106 l−1)
CRP (mg ml−1) 6.4 (14.1) 2.9 (2.8) 0.167
Fibrinogen (g l−1) 3.3 (0.76) 2.9 (0.7) 0.032
Haptoglobin (g l−1) 1.2 (0.74) 1.1 (0.6) 0.611
was observed in 6 out of 37 (16%) patients and in 3
out 40 controls (7.5%). Also, serum fibrinogen con-
centration was significantly higher in the patient group
than in the control group (Table 1). Furthermore, we
found that the CRP concentration was almost two
times higher in patients than in controls (6.4 vs. 3.9)
but the difference was not statistically significant.
In haptoglobin values no significant difference was
observed (Table 1). Increased B-leukocyte count, CRP
level or serum fibrinogen concentration was found in
9 out 37 patients (24%) and in 4 out 40 (10%) controls
(Fisher’s exact test; P = 0.085). We found significant
correlation between the plasma IL-6 concentration
and both peripheral blood while blood cell counts
(correlation coefficient r = 0.51, P = 0.001) and
plasma CRP concentration (r = 0.42, P = 0.0088).
In addition, CRP had a positive correlation with
time after seizure (r = 0.51, P = 0.009) and CSF
leukocyte count had a negative correlation with time
after seizure (r = −0.40, P = 0.05).
DISCUSSION
We found some evidence of an acute phase reaction
provoked by an uncomplicated epileptic seizure in
24% of our patients, but the difference was not
significant compared with controls (10%). As a
group, our patients had statistically higher plasma
fibrinogen levels than the controls, and there was
a trend towards increased CRP concentrations. We
showed a statistically significant positive correlation
with plasma CRP level and delay of sampling time
after the seizure.
The acute phase reaction is usually caused by
inflammation or tissue injury. In patients with head
trauma and stroke, the magnitude of acute phase
response correlates with the severity and outcome of
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the injury9. It has been shown that status epilepticus
and even single seizures may cause neuronal injury,
as shown by increased levels of serum neuron-specific
enolase enzyme (s-NSE)10. However, none of our
patients had any clinical evidence of acute brain
damage or increased levels of S-NSE11. Thus, the
acute phase reaction is most probably caused by the
seizure activity itself.
In patients with severe traumatic brain injury the
acute phase response correlated with CSF and plasma
levels of IL-6, and maximum IL-6 concentrations in
plasma correlated with the peak levels of acute phase
proteins10. Increased expression of several cytokines
has been reported in brains of animals treated with
a convulsant agent, kainic acid. We have previously
reported that the CSF concentrations of IL-6 were
substantially higher than in plasma, suggesting an
intrathecal production of IL-67.
Central nervous system production of IL-6 can
stimulate increased production of IL-6 in peripheral
blood12, which subsequently activates the acute phase
reaction. In our study, plasma IL-6 concentrations
correlated with peripheral blood leukocyte counts and
CRP.
Patients with single remote symptomatic or idio-
pathic/cryptogenic seizures have been reported to have
transient CSF pleocytosis in 11–34% of the cases3, 6,
in line with the present study (16%). In our series,
pleocytosis was mild (the maximum concentration
of CSF leukocytes was 9 × 106 l−1), comparable
with the values reported by Devinsky et al.1, but
others have found concentrations up to 65–80 ×
106 l−1 2, 13. It has been suggested that the etiology
of the seizure and the timing of the sampling relate
to the prevalence and magnitude of CSF pleocytosis.
Pleocytosis is most commonly found when CSF
samples are obtained within 12 hours of the last
seizure1. In fact, Devinsky et al.1 reported that in
a majority of their patients CSF pleocytosis was
found within 90 min after the seizures. Our study
further showed a negative correlation with the time
lag between the seizures and sampling. Patients with
idiopathic/cryptogenic seizures have lower frequency
of CSF pleocytosis and the highest number of CSF
leukocytes is observed in patients with seizures due
to acute CNS damage (such as trauma, infection and
stroke) and status epilepticus4.
In summary, we found that seizures provoke a
production of cytokines such as IL-6 that may in turn
cause an activation of the acute phase reaction. Thus,
CSF pleocytosis and increase in some indicators of
inflammation should not automatically be attributed
to systemic or CNS infections in patients with acute
seizures.
REFERENCES
1. Devinsky, O., Nadi, S., Theodore, W. H. and Porter, R. J. Cere-
brospinal fluid pleocytosis following simple, complex partial,
and generalized tonic–clonic seizures. Annals of Neurology
1988; 23: 402–403.
2. Schmidley, J. W. and Simon, R. P. Postictal pleocytosis.
Annals of Neurology 1981; 9: 81–84.
3. Prokesch, R. C., Rimland, D., Petrini, J. L. Jr and Fein,
A. B. Cerebrospinal fluid pleocytosis after seizures. Southern
Medical Journal 1983; 76: 322–327.
4. Barry, E. and Hauser, W. A. Pleocytosis after status
epilepticus. Archives of Neurology 1994; 51: 190–193.
5. Toyosawa, K. Changes of peripheral leukocyte counts by
electrically induced convulsion in rabbits. Nippon Seirigaku
Zasshi. Journal of the Physiological Society of Japan 1975;
37: 297–306.
6. Peltola, J., Hurme, M., Miettinen, A. and Kera¨nen, T. Elevated
levels of interleukin-6 may occur in cerebrospinal fluid from
patients with recent epileptic seizures. Epilepsy Research
1998; 31: 129–133.
7. Peltola, J., Palmio, J., Korhonen, L. et al. Interleukin-6 and
interleukin-1 receptor antagonist in cerebrospinal fluid from
patients with recent tonic–clonic seizures. Epilepsy Research
2000; 41: 205–211.
8. Xing, Z., Gauldie, J., Baumann, H., Jordana, M., Lei, X. F. and
Achong, M. K. IL-6 is an anti-inflammatory cytokine required
for controlling local or systemic acute inflammatory responses.
Journal of Clinical Investigation 1998; 101: 311–320.
9. Kossmann, T., Hans, V. H., Imhof, H. G., Stocker, R., Grob, P.,
Trentz, O. and Morganti-Kossmann, C. Intrathecal and serum
interleukin-6 and the acute phase response in patients with
severe traumatic brain injuries. Shock 1995; 4: 311–317.
10. Correale, J., Rabinowicz, A. L., Heck, C. N., Smith, T. D.,
Loskota, N. J. and DeGiorgio, C. M. Status epilepticus
increases CSF levels of neuron-specific enolase and alters the
blood-brain barrier. Neurology 1998; 50: 1388–1391.
11. Palmio, J., Peltola, J., Vuorio, P., Suhonen, J. and
Kera¨nen, T. Normal neuron-specific enolase and S-100 protein
levels in patients with recent non-complicated tonic–clonic
seizures. Journal of the Neurological Sciences 2001; 183:
27–31.
12. Reyes, T. M. and Coe, C. L. The proinflammatory cytokine
network: interactions in the CNS and blood of rhesus monkeys.
American Journal of Physiology 1998; 274: 139–144.
13. Edwards, R., Schmidley, J. W. and Simon, R. P. How often
does a CSF pleocytosis follow generalized convulsions?
Annals of Neurology 1983; 13: 460–462.
